The FDA has approved an expanded indication for luspatercept (Reblozl) for the first-line treatment of anemia in patients with low-risk MDS who may require blood transfusions.
The Fiji TimesGeron says blood cancer drug succeeds in late-stage study, shares surge fijitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fijitimes.com Daily Mail and Mail on Sunday newspapers.